The Pan American Health Organization
Promoting Health in the Americas

 Safe Hospitals

Health Surveillance & Disease Prevention & Control — Communicable Diseases: 
Acute Respiratory Infections - Anthrax - Antimicrobial Resistance - Campylobacter - Chagas -
Cholera - Dengue - Diarrheal/Enteric Diseases - Disease Outbreak News -
Emerging/Reemerging Diseases - Filariasis - Hantavirus - InfluenzaAvian |  Pandemic |  Seasonal - International Health Regulations - Leishmaniasis - Leprosy - Malaria -
Neglected Diseases - Parasitic Diseases - Rabies - Research - Salmonella - Shigella - Smallpox -
Tuberculosis - West Nile Virus  - Yellow Fever  -
Health Analysis & Statistics - Chronic Diseases - Veterinary Public Health

Full Text (89 pp, PDF)
(chapters in English, Spanish and Portuguese, according to language of title)

Cover and Contents
Executive Summary
1. Welcoming Remarks
2. Objectives of the Meeting

3. Background
3.1. Introduction and summary of previous recommendations
3.2. Summary description of participating institutions (by country)

4. Country Reports on Current Status of Emerging Disease Surveillance


5. Special Topics
5.1 Verification and response to EID outbreaks and the WHO electronic disease surveillance
5.2 Regional system for epidemiological surveillance
5.3 Global Influenza Surveillance
5.4 Síndrome Urémico Hemolítico
5.5 Hantavirus Pulmonary Syndrome
5.6 Resistencia Antimicrobiana/Tuberculosis
5.7 Enfoque Sindrómico
5.8 Enfermedades Infecciosas Emergentes en Perú
5.9 Sistema Regional de Vigilancia Epidemiológica da las Enfermedades Transmitidas por Alimentos

6. Plan of Action
6.1 Disease Syndromes
6.2 Infectious Agents for Disease Syndromes
6.3 Specific Pathologies
6.4 Surveillance for Antimicrobial Resistance
6.5 Syndromes/Diseases for Initial Surveillance
6.6 Specimens
6.7 Reagents
6.8 Laboratory Tests
6.9 Provision of Reagents
6.10 Quality Control
6.11 Equipment
6.12 Project Management
6.13 Financial support
6.14 Associated Institutions
6.15 Study Sites and Populations
6.16 Number of Subjects
6.17 Follow-up of Patients
6.18 Outbreak Investigations
6.19 Questionnaire
6.20 Specimen Banking
6.21 Communications/Banking
6.22 Training
6.23 Evaluations
6.24 Integration of the Network to the National Surveillance Systems
6.25 National Technical Committee
6.26 Surveillance of HUS and Influenza

7. Conclusions

8. Annexes
1. Surveillance of Hemolytic Uremic Syndrome
2. Surveillance of Influenza
3–4. Relatórios Grupos 1 e 2
5. List of Participants

Second Meeting of a Surveillance Network for Emerging Infectious Diseases (EIDs) in the Southern Cone Region

laboratory networks

(Brasilia, Brazil, 11–13 May 1999)

The general objective of this second meeting was to continue efforts to establish a functional network of laboratories within the greater Southern Cone Region—Argentina, Bolivia, Brazil, Chile, Paraguay and Uruguay—capable of obtaining accurate, high-quality laboratory results on new, emerging and re-emerging infections found in the Region.

The specific objectives include the following:

  1. review and update the Plan of Action prepared during the first meeting held in Buenos Aires, April 1998;
  2. describe the current status of emerging infections in the participating countries;
  3. prepare common protocols for specific problems including Hemolytic uremic syndrome (HUS), Influenza, and Hantavirus Pulmonary Syndrome;
  4. discuss interaction between epidemiology and laboratory, and
  5. discuss possibilities for cooperation among participating countries and international reference laboratories.

The Plan of Action prepared in Buenos Aires was slightly modified to include minor changes and the protocols for surveillance of certain disease syndromes.

The participants reiterated the syndrome and diseases that were selected for initial surveillance: in the original Plan:

  • Influenza
  • Antimicrobial resistance, especially for tuberculosis
  • Acute diarrhea, especially bloody diarrhea leading to HUS
  • Hantavirus pulmonary syndrome and hantaviral disease

Seven disease syndromes were selected for inclusion in the proposed surveillance program. A definition of each syndrome is given below:

  1. Undifferentiated febrile syndrome: Fever (axillary temperature 38º C) that has no obvious etiology and has no more than 7 days evolution in a previously healthy person 5 years of age or older.
  2. Hemorrhagic fever syndrome: An acute febrile (axillary temperature 38º C) hemorrhagic illness with or whithout. evidence of capillary fragility in a person of any age.
  3. Febrile icteric syndrome: Febrile patients (axillary temperature 38º C) more than one year of age with acute or insidious onset of icterus in whom there is no detectable cholelithiasis or biliary obstruction or malignancy.
  4. Acute respiratory distress syndrome: A febrile illness (temp. 38° C) more than 5 years of age characterized by bilateral diffuse interstitial edema, with respiratory compromise requiring supplemental oxygen, developing within 72 hours of hospitalization, and occurring in a previously healthy person.
  5. Unexpected death syndrome: Previously healthy persons, 5-49 years of age, who are hospitalized (or admitted to an emergency room) with a life threatening illness with hallmarks of an infectious disease for which no cause is identified.
  6. Infectious neurologic syndrome: Febrile neurologic symptoms with clear CSF in a non-immunodepressed patient.
  7. Enteric syndrome: Bloody or non bloody, acute diarrhea, with fever or not, in children or adults.

Again the surveillance for antimicrobial resistance was considered of great importance and agreed for:

  1. Resistance of Streptococcus pneumoniae and Haemophilus influenzae to penicillin;
  2. Resistance of Salmonella and >Shigella to one or more drugs;
  3. Vancomycin-resistant Enterococcus; and
  4. Yeast and filamentous fungi.

The role of associated institutions that can to provide support to the network was highlighted. These institutions include CDC, INPPAZ, PAHO and WHO.

The participants agreed that the next meeting should be held in conjunction with the meeting of the network of the Amazon Region, and take place in Atlanta, Georgia, just before the International Conference on Emerging Infectious Diseases, July 2000.

Regional Office for the Americas of the World Health Organization
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America
Tel.: +1 (202) 974-3000 Fax: +1 (202) 974-3663

© Pan American Health Organization. All rights reserved.